All Reports

The U.S. digital health market is predicted to reach US$191.64 billion in 2025, progressing at a CAGR of 28.40%, over the period 2021-2025. The factors such as increasing geriatric population, growing usage of mobile devices, surging prevalence of arthritis, hike in healthcare expenditure, expanding urbanization and mounting penetration of internet users would drive the growth of the market. Ho ..

The global CDMO market is estimated to reach US$241.3 billion in 2024, growing at a CAGR of 9.80% for the period spanning from 2020 to 2024. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations and growing demand fo ..

The global ibuprofen market is projected to reach US$7.54 billion in 2024, progressing at a CAGR of 2.47%, over the period 2020-2024. The factors such as upsurge in healthcare expenditure, rising prevalence of arthritis, surging incidence of cancer cases, expanding urbanization and escalating sales of analgesic drugs would drive the growth of the market. However, the market growth would be chal ..

The global API market is forecasted to reach US$270.83 billion in 2024, growing at a CAGR of 6.5% for the period spanning 2020-2024. The factors such as increasing ageing population, rising healthcare expenditure per capita, growing cancer patients, inclining orphan drugs industry and accelerating outsourcing of API drugs are expected to drive the market. However, growth of the industry would b ..

The global contact lens market is forecasted to reach US$9.92 billion in 2024, growing at a CAGR of 7% for the period spanning 2020-2024. The factors such as increasing spending on eyewear products by population, rising prevalence of myopia, rapid urbanization, improving consumer confidence index and accelerating personal disposable income are expected to drive the market. However, growth of th ..

The global dry eye disease market is predicted to reach US$4.28 billion in 2024, witnessing growth at a CAGR of 5.23%, over the period 2020-2024. The factors such as increasing geriatric population, growing burden of diabetes, rising healthcare expenditure, surging prevalence of arthritis and upswing in air pollution are expected to drive the market. A few notable trends include the emerging nu ..

The global cough, cold & allergy (CCA) treatment market is expected to reach US$35.36 billion in 2024, growing at a CAGR of 3.90%, for the duration spanning 2020-2024. The factors such as rising demand for over-the-counter (OTC) medicines, upswing in air pollution, growth in the geriatric population, increasing pharmaceutical R&D spending, rising prevalence of asthma and upsurge in heal ..

The global nucleic acid therapeutics market is expected to record a value of US$7.23 billion in 2024, increasing at a CAGR of 33.3%, for the duration spanning 2020-2024. The factors such as rising incidences of new cancer cases, rising penetration of gene therapy, increasing pharmaceutical R&D spending, rise in prevalence of diabetes, upsurge in healthcare expenditures and rapid advances in ..

The global prostate cancer market is anticipated to reach US$14.41 billion in 2024, witnessing growth at a CAGR of 4.62%, over the period 2020-2024. Factors such as increasing geriatric population, rising healthcare expenditure, surging obese population, expanding urbanization, new drug approvals are expected to drive the market. The growth of the market would be challenged by severe side effec ..

The global hemophilia market is anticipated to reach US$13.86 billion in 2024, growing at a CAGR of 5.61% during the period spanning 2020-2024. The growth in the market has been driven by factors like increasing healthcare expenditure and surging identified hemophilia patient volume. The market is expected to face certain challenges such as high cost of treatment and reluctance to switch to new ..